The present invention provides a method for modulating the alkaloid content of a plant (e.g. a tobacco plant), the method comprising modifying said plant by modulating the activity or expression of at least one protein kinase. The present invention also provides for the use of at least protein kinase gene for modulating the alkaloid content of a plant, as well as tobacco cells, plants, plant propagation materials, harvested leaves, processed tobaccos, or tobacco products obtainable in accordance with the invention.

The present invention relates to isolated nucleic acid molecules and their corresponding encoded polypeptides. The present invention further relates to the uses of these nucleic acid molecules and polypeptides. For example, the nucleic acid molecules and polypeptides could be used in making enzymes or used to make plants, plant cells, plant materials or seeds of a plant having such modulated growth or phenotype characteristics that are altered with respect to wild type plants grown under similar conditions.

The present invention relates to an atranorin biosynthesis gene derived from a lichen Stereocaulon alpinum, an Ascochyta rabiei ATR-11 strain (Accession Number: KACC 83048BP) for producing atranorin into which the gene is introduced, and a method of producing atranorin using the above strain. A lichen-derived metabolite, particularly atranorin, may be produced from the Ascochyta rabiei ATR-11 strain into which the atranorin biosynthesis gene according to the present invention is introduced. Atranorin produced from the above strain can be utilized and industrialized in a variety of ways, such as pharmaceutical compositions, food compositions, health functional foods, and feed compositions.

The present invention relates to an atranorin biosynthesis gene derived from a lichen Stereocaulon alpinum, an Ascochyta rabiei ATR-11 strain (Accession Number: KACC 83048BP) for producing atranorin into which the gene is introduced, and a method of producing atranorin using the above strain. A lichen-derived metabolite, particularly atranorin, may be produced from the Ascochyta rabiei ATR-11 strain into which the atranorin biosynthesis gene according to the present invention is introduced. Atranorin produced from the above strain can be utilized and industrialized in a variety of ways, such as pharmaceutical compositions, food compositions, health functional foods, and feed compositions.

The present disclosure provides compositions and methods for providing broad-based resistance to fungal pathogens, such as a Fusarium fungi, and plants derived therefrom.

Provided herein are KRN2 gene controlling kernel row number in plant, molecular markers closely linked to KRN2 and their application in molecular breeding.